Leaked API keys are nothing new, but the scale of the problem in front-end code has been largely a mystery - until now. Intruder's research team built a new secrets detection method and scanned 5 ...

Chrome 144 introduces the groundbreaking Temporal API, revolutionizing date and time management in JavaScript. As a modern alternative to the criticized Date object, Temporal resolves parsing ...

Follow ZDNET: Add us as a preferred source on Google. Imagine you're using Windows 11 and you've learned that an upgrade is available. You struggle to approve the upgrade, but you know you will ...

Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into ...

LOS GATOS, CA / / February 12, 2026 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results ...

Churchill Capital Corp X (“Churchill X”) (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced that its shareholders have approved the previously announced business ...

While Bethesda has made its position very clear on Fallout game locations (it'll never stray outside of the United States) that doesn't stop people dreaming about exploring irradiated wastelands in ...

DUBAI, UAE and PANAMA CITY, Jan. 22, 2026 /PRNewswire/ -- ATOM Group, a global commercial enterprise operating at the intersection of digital platforms, content, and talent commercialization, today ...

Artificial-intelligence workloads are pushing semiconductor design to a point where traditional scaling strategies are running out of room. Performance improvements that once came from shrinking ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

HANGZHOU, China--(BUSINESS WIRE)--Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of ...